Morgan Stanley: Nutanix Investors Will Ultimately Reward Business Investments
Nutanix Inc (NASDAQ: NTNX) shares were slipping Friday morning in reaction to the fiscal fourth-quarter results released after the close Thursday.
The Analyst
Morgan Stanley analyst Katy Huberty maintained an Equal-weight rating on Nutanix and increased the price target from $55 to $57.
The Thesis
Expense growth at Nutanix was directed toward better segmenting the salesforce; improving the core platform; multicloud software; and future services, Huberty said in the Friday note. (See the analyst's track record here.)
The business investments led to a sharp reduction in Morgan Stanley's EPS and FCF estimates for 2019, the analyst said.
Yet Huberty said investors may do well to focus on the company's top-line and billings growth momentum near-term, especially due to stronger-than-expected software and support billings growth, accelerating HCI market growth and positive customer and partner feedback on the Nutanix software roadmap.
The investments are self-funded with the company's FCF in 2018, while 2019 is likely to be FCF-neutral, the analyst said.
Although the company's guidance that calls for Q1 revenue of $295 million to $310 million and billings of $370 million to $390 million appears soft, Huberty said the shortfall relative to her estimate is due to the faster run-off of hardware revenue and her 12.5 times bill-to-revenue ratio estimate, which is below the guidance for 12.6 times.
Morgan Stanley projects that Nutanix can sustain 40-percent billings growth over the next two years.
" ... We think investors will ultimately reward the company for investing and modestly raise [the price target] to $57," Huberty said.
The Price Action
Nutanix shares have gained about 72 percent year-to-date.
The stock was slipping 6.8 percent off the open to $56.66 Friday.
Related Links:
JPMorgan Upgrades Nutanix Ahead Of Q4 Report, Sees Balanced Risk-Reward Profile
Nutanix Shares Under Pressure Following Public Cloud Delay
Latest Ratings for NTNX
Date | Firm | Action | From | To |
---|---|---|---|---|
Dec 2020 | Morgan Stanley | Maintains | Equal-Weight | |
Dec 2020 | Oppenheimer | Upgrades | Perform | Outperform |
Nov 2020 | Morgan Stanley | Maintains | Equal-Weight |
View More Analyst Ratings for NTNX
View the Latest Analyst Ratings
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Katy Huberty Morgan StanleyAnalyst Color Earnings News Price Target Reiteration Analyst Ratings Best of Benzinga